Genzyme Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Genzyme stocks.

Genzyme Stocks Recent News

Date Stock Title
Nov 20 VYGR Voyager selects gene therapy development candidate for Alzheimer’s disease
Nov 20 VYGR Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease
Nov 19 EXAS Exact Sciences Corporation (EXAS): Among the Best Genomics Stocks to Buy Right Now
Nov 19 BMRN BioMarin Pharmaceutical Inc. (BMRN): Among the Best Genomics Stocks to Buy Right Now
Nov 19 EXAS Exact Sciences Corporation (EXAS) Jefferies London Healthcare Conference (Transcript)
Nov 18 ALNY Alnylam releases encouraging interim data on nucresiran for ATTR amyloidosis
Nov 18 VYGR Voyager Therapeutics' Tracer Platform Targets CNS Market: Here's Why I'm Neutral
Nov 18 ALNY ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study
Nov 18 ALNY Alnylam reveals trial outcomes of nucresiran for ATTR amyloidosis treatment
Nov 18 EXAS EXAS Stock Set to Benefit From Favorable Study Data Backing MCED Test
Nov 17 ALNY Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04) Showing Rapid Knockdown of TTR that is Sustained at Six Months Following a Single Dose
Nov 16 BMRN BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024
Nov 16 EXAS Chairman of The Board & CEO of Exact Sciences Picks Up 2.7% More Stock
Nov 15 EXAS Exact Sciences showcases early cancer detection test data at AACR meeting
Nov 14 PTCT FDA Grants Conditional Approval For PTC Therapeutics' Gene Therapy As First Ever With Direct Administration In Brain
Genzyme

Sanofi Genzyme is an American biotechnology company based in Cambridge, Massachusetts. Since its acquisition in 2011, Genzyme has been a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world’s third-largest biotechnology company, employing more than 11,000 people around the world. As a subsidiary of Sanofi, Genzyme has a presence in approximately 65 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories. Its products are also sold in 90 countries. In 2007, Genzyme generated $3.8 billion in revenue with more than 25 products on the market. In 2006 and 2007, Genzyme was named one of Fortune Magazine’s “100 Best Companies to Work for”. The company donated $83 million worth of products worldwide; in 2006, it made $11 million in cash donations. In 2005, Genzyme was awarded the National Medal of Technology, the highest level of honor awarded by the president of the United States to America’s leading innovators.

Browse All Tags